Biotech Industry: Small Innovators Outflank Big Caps As Blockbuster Drug Patent Cliff Looms
Biotech behemoths like Celgene and Gilead struggled in the third quarter, leaving room for nimble innovators like Neurocrine, Exelixis and Juno Therapeutics to swipe headlines after crushing expectations.